Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Astraea Therapeutics logo — Empowering patients fighting substance addiction

Astraea Therapeutics

Empowering patients fighting substance addiction

Founded 2009 6 employees Biotechnology, Health Care +2

General Information

Company Name Astraea Therapeutics
Founded Year 2009
Founders / Decision Makers
Team member
Employees 6
Industries Biotechnology, Health Care, Health and Wellness +1
Social

Get notified when Astraea Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Astraea Therapeutics

Astraea Therapeutics is a clinical-stage startup founded in 2009 with the mission of empowering patients fighting substance addiction. The company focuses on developing life-changing medicines for individuals struggling with addiction to opioid painkillers, smoking, and habitual psychostimulants. Astraea's innovative platform technology revolves around the neurobiology of relapse. They are currently working on oral medicines targeting two key pathways in the brain – one genetically linked to addictive behaviors and the other identified through clinical imaging to be altered in patients grappling with addiction. Astraea Therapeutics is at the forefront of addressing a pressing global issue and offers promising solutions by leveraging cutting-edge scientific research. The company's approach to developing medicines that target specific pathways in the brain demonstrates a deep understanding of the underlying biology of addiction. Despite the absence of specific details regarding their headquarters, last investment, or investors, their relentless focus on revolutionizing addiction treatment makes Astraea a compelling prospect for venture capitalists looking to invest in startups that are making a tangible impact in the healthcare sector. With a strong emphasis on research and development, Astraea Therapeutics has the potential to carve out a significant presence in the market and offer substantial returns for investors.

Taxonomy: substance addiction, neurobiology, clinical-stage company, opioid painkillers, smoking addiction, psychostimulants, addictive behaviors, oral medicines, brain pathways, genetics of addiction, relapse prevention, clinical imaging, patient empowerment, life-changing medicines, addiction biology

No funding data available for Astraea Therapeutics yet.

Get notified when Astraea Therapeutics raises funding

Astraea Therapeutics Alternatives & Competitors

Astraea Therapeutics vs
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. United States

Uniquely poised to disrupt pain therapy.

Series B
57 employees
Biotechnology, Health Care
Astraea Therapeutics vs
Notable
Notable United States

Notable is a mission-driven company transforming the way cancer is treated

Unknown
33 employees
Biotechnology, Health Care
Astraea Therapeutics vs
MindMed
MindMed United States

MindMed is a clinical-stage biopharma company developing novel products to treat brain health disord...

Post Ipo Equity
103 employees
Biotechnology, Health Care

FAQ About Astraea Therapeutics

Empowering patients fighting substance addiction
Astraea Therapeutics was founded in 2009.
Astraea Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness, Pharmaceutical.
Astraea Therapeutics has approximately 6 employees.
Top alternatives and competitors to Astraea Therapeutics include Latigo Biotherapeutics, Inc., Notable, MindMed, 江苏科信医药销售有限公司, Kinnate Biopharma Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Astraea Therapeutics and Latigo Biotherapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Astraea Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy